Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia

被引:4
作者
Ilich, Anton [1 ,2 ]
Gernsheimer, Terry B. [3 ,4 ]
Triulzi, Darrell J. [5 ]
Herren, Heather [6 ]
Brown, Siobhan P. [6 ]
Holle, Lori A. [2 ,7 ]
Lucas, Andrew T. [8 ]
de Laat, Bas [9 ]
El Kassar, Nahed [10 ]
Wolberg, Alisa S. [2 ,7 ]
May, Susanne [6 ]
Key, Nigel S. [1 ,2 ,7 ,11 ]
机构
[1] Univ N Carolina, Dept Med, Div Hematol, Sch Med, Chapel Hill, NC USA
[2] Univ N Carolina, UNC Blood Res Ctr, Sch Med, Chapel Hill, NC USA
[3] Univ Washington, Dept Med Hematol, Seattle, WA USA
[4] Univ Washington, Seattle Canc Care Alliance, Seattle, WA USA
[5] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA
[6] Univ Washington, Dept Biostat, Seattle, WA USA
[7] Univ N Carolina, Dept Pathol & Lab Med, Sch Med, Chapel Hill, NC USA
[8] Univ N Carolina, Div Pharmacotherapy & Expt Therapeut, Eshelman Sch Pharm, Chapel Hill, NC USA
[9] Synapse Res Inst, Maastricht, Netherlands
[10] NHLBI, Div Blood Dis & Resources, Washington, DC USA
[11] Univ N Carolina, Sch Med, 8008B Mary Ellen Jones Bldg,CB 7035,116 Manning Dr, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
VASCULAR OCCLUSIVE EVENTS; FIBRINOLYTIC ACTIVATION; PLATELET TRANSFUSIONS; NORMAL MENSTRUATION; CONTROLLED-TRIAL; TRAUMA PATIENTS; CRASH-2; WOMEN; DIAGNOSIS; DEATH;
D O I
10.1182/bloodadvances.2022008255
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The American Trial Using Tranexamic Acid (TXA) in Thrombocytopenia (A-TREAT, NCT02578901) demonstrated no superiority of TXA over placebo in preventing World Health Organization (WHO) grade 2 or higher bleeding in patients with severe thrombocytopenia requiring supportive platelet transfusion following myeloablative therapy for hematologic disorders. In this ancillary study, we sought to determine whether this clinical outcome could be explained on the basis of correlative assays of fibrinolysis. Plasma was collected from A-TREAT participants (n = 115) before the initiation of study drug (baseline) and when TXA was at steady-state trough concentration (follow-up). Global fibrinolysis was measured by 3 assays: euglobulin clot lysis time (ECLT), plasmin generation (PG), and tissue-type plasminogen activator (tPA)-challenged clot lysis time (tPA-CLT). TXA was quantified in follow-up samples by tandem mass spectrometry. Baseline samples did not demonstrate fibrinolytic activation by ECLT or tPA-CLT. Furthermore, neither ECLT nor levels of plasminogen activator inhibitor-1, tPA, plasminogen, alpha2-antiplasmin, or plasmin-antiplasmin complexes were associated with a greater risk of WHO grade 2+ bleeding. TXA trough concentrations were highly variable (range, 0.7-10 mu g/mL) and did not correlate with bleeding severity, despite the fact that plasma TXA levels correlated strongly with pharmacodynamic assessments by PG (Spearman r, -0.78) and tPA-CLT (r, 0.74). We conclude that (1) no evidence of fibrinolytic activation was observed in these patients with thrombocytopenia, (2) trough TXA concentrations varied significantly between patients receiving the same dosing schedule, and (3) tPA-CLT and PG correlated well with TXA drug levels.
引用
收藏
页码:900 / 908
页数:9
相关论文
共 40 条
  • [1] Acute promyelocytic leukemia: preventing early complications and late toxicities
    Abedin, Sameem
    Altman, Jessica K.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 10 - 15
  • [2] Boneu B, 1987, Transfus Med Rev, V1, P182
  • [3] Altered Fibrinolysis in Hematological Malignances
    Bonlokke, Soren Thorgaard
    Ommen, Hans Beier
    Hvas, Anne-Mette
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (05) : 569 - 580
  • [4] Antifibrinolytics for heavymenstrual bleeding
    Bryant-Smith, Alison C.
    Lethaby, Anne
    Farquhar, Cindy
    Hickey, Martha
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (04):
  • [5] Platelet transfusion and tranexamic acid to prevent bleeding in outpatients with a hematological disease: A Dutch nationwide survey
    Cornelissen, Loes L.
    Caram-Deelder, Camila
    Meier, Romy T.
    Zwaginga, Jaap Jan
    Evers, Dorothea
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (03) : 362 - 370
  • [6] Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia Conclusions from Clinical Trials and Current Controversies
    Crighton, Gemma L.
    Estcourt, Lise J.
    Wood, Erica M.
    Stanworth, Simon J.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (03) : 541 - +
  • [7] Tranexamic Acid in Patients Undergoing Noncardiac Surgery
    Devereaux, P. J.
    Marcucci, M.
    Painter, T. W.
    Conen, D.
    Lomivorotov, V
    Sessler, D., I
    Chan, M. T., V
    Borges, F. K.
    Martinez-Zapata, M. J.
    Wang, C-Y
    Xavier, D.
    Ofori, S. N.
    Wang, M. K.
    Efremov, S.
    Landoni, G.
    Kleinlugtenbelt, Y., V
    Szczeklik, W.
    Schmartz, D.
    Garg, A. X.
    Short, T. G.
    Wittmann, M.
    Meyhoff, C. S.
    Amir, M.
    Torres, D.
    Patel, A.
    Duceppe, E.
    Ruetzler, K.
    Parlow, J. L.
    Tandon, V
    Fleischmann, E.
    Polanczyk, C. A.
    Lamy, A.
    Astrakov, S., V
    Rao, M.
    Wu, W. K. K.
    Bhatt, K.
    de Nadal, M.
    Likhvantsev, V. V.
    Paniagua, P.
    Aguado, H. J.
    Whitlock, R. P.
    McGillion, M. H.
    Prystajecky, M.
    Vincent, J.
    Eikelboom, J.
    Copland, I
    Balasubramanian, K.
    Turan, A.
    Bangdiwala, S., I
    Stillo, D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (21) : 1986 - 1997
  • [8] THE FIBRINOLYTIC ENZYME-SYSTEM IN NORMAL MENSTRUATION AND EXCESSIVE UTERINE BLEEDING AND THE EFFECT OF TRANEXAMIC ACID
    DOCKERAY, CJ
    SHEPPARD, BL
    DALY, L
    BONNAR, J
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1987, 24 (04): : 309 - 318
  • [9] Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
    Estcourt, Lise J.
    Desborough, Michael
    Brunskill, Susan J.
    Doree, Carolyn
    Hopewell, Sally
    Murphy, Michael F.
    Stanworth, Simon J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (03):
  • [10] Fluid Mechanics of Blood Clot Formation
    Fogelson, Aaron L.
    Neeves, Keith B.
    [J]. ANNUAL REVIEW OF FLUID MECHANICS, VOL 47, 2015, 47 : 377 - 403